Brazil wants to buy pharmaceutical manufacturing technology from the Ukraine as part of a $4.5bn investment plan.
News of the deal emerged earlier this week, just one month after Ukrainian officials visited Sao Paulo as part of a 15 country ‘roadshow’ designed to attract investment.
At the time José Barouki, director of trade and investment company Daruvar SA, said: "We want to build the mini-tractors production plant in Ukraine as well as purchase shipbuilding and pharmaceutical manufacturing technology.”
The deal – terms of which have not been disclosed – builds on a number of existing agreements between Brazilian and Ukrainian firms.
In May, Brazilian state pharmaceutical group Farmanguinhos/Fiocruz bought 3.5 million vials of genetically engineered human insulin from Ukrainian insulin producer Indar. The countries also have also signed a preliminary agreement to establish bilateral insulin production in Brazil using Ukrainian technology by 2014.